Delivery Order SPE2DB25D3006-SPE2DB25FXKDW
Award Date 8/21/25
Potential Completion Date 9/12/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,117.48 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-competitive set-aside and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This firm fixed-price delivery order, valued at $8,381.10, is scheduled for completion by September 11, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the company's proven...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for XEOMIN 100 Unit vials with a ceiling value of $8,381.10. This firm fixed price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $3,039.40 to AmerisourceBergen Drug Corp for 50-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This competitive award, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, carries firm fixed pricing and represents a non-set-aside contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 21, 2025, with a ceiling value of $1,955.59 for the supply of XEOMIN 100 Unit Vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made through competitive procedures with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $16,762.20 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, a botulinum toxin product commonly used in medical and cosmetic applications. This firm fixed-price delivery order, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive award to the incumbent vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Xeomin 100 unit vials. The contract is valued at $2,793.70 and carries a firm fixed price structure with an ultimate completion date of August 13, 2025. This non-set-aside award represents a competitive procurement action and will be performed at the contractor's Conshohocken facility....
- The Defense Logistics Agency awarded a $15,997.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin product used for medical and cosmetic applications. The award, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen's Conshohocken, Pennsylvania facility serves as the place of performance for this transaction. This delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of XEOMIN 100 UT vials valued at $11,174.80. This is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and was awarded through open competition without set-aside provisions. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and...